Reelin-mediated signaling during normal and pathological forms of aging

Aging and Disease

Volumn 1, Issue 1, 2010, Pages 12-29

  Doehner, Jana ^a   Knuesel, Irene ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Aging; Alzheimer's disease; APP processing; Cognitive impairments; In utero infection; Inflammation; Mid and late gestation; Neurodegeneration; polyriboinosinic polyribocytodilic acid; Tau phosphorylation

Indexed keywords

MUS MUSCULUS;

EID: 80755185579     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: None     Document Type: Review

References (137)

1. Kohno S, Kohno T, Nakano Y, Suzuki K, Ishii M, Tagami H, Baba A, Hattori M (2009). Mechanism and significance of specific proteolytic cleavage of Reelin. Biochem Biophys Res Commun, 380:93-7.
2. Lambert de Rouvroit C, de Bergeyck V, Cortvrindt C, Bar I, Eeckhout Y, Goffinet AM (1999). Reelin, the extracellular matrix protein deficient in reeler mutant mice, is processed by a metalloproteinase. Exp Neurol, 156:214-7.
3. Kubo K, Mikoshiba K, Nakajima K (2002). Secreted Reelin molecules form homodimers. Neurosci Res, 43:381-8.
4. Chameau P, Inta D, Vitalis T, Monyer H, Wadman WJ, van Hooft JA (2009). The N-terminal region of reelin regulates postnatal dendritic maturation of cortical pyramidal neurons. Proc Natl Acad Sci U S A,106:7227-32.
5. Jossin Y, Gui L, Goffinet AM (2007). Processing of Reelin by embryonic neurons is important for function in tissue but not in dissociated cultured neurons. J Neurosci, 27:4243-52.
6. Jossin Y, Ignatova N, Hiesberger T, Herz J, Lambert de Rouvroit C, Goffinet AM (2004). The central fragment of Reelin, generated by proteolytic processing in vivo, is critical to its function during cortical plate development. J Neurosci, 24:514-21.
7. Hoe HS, Lee KJ, Carney RS, Lee J, Markova A, Lee JY, Howell BW, Hyman BT, Pak DT, Bu G, Rebeck GW (2009). Interaction of reelin with amyloid precursor protein promotes neurite outgrowth. J Neurosci, 29:7459-73.
8. de Bergeyck V, Nakajima K, Lambert de Rouvroit C, Naerhuyzen B, Goffinet AM, Miyata T, Ogawa M, Mikoshiba K (1997). A truncated Reelin protein is produced but not secreted in the 'Orleans' reeler mutation (Reln[rl-Orl]). Brain Res Mol Brain Res, 50:85-90.
9. Nakano Y, Kohno T, Hibi T, Kohno S, Baba A, Mikoshiba K, Nakajima K, Hattori M (2007). The extremely conserved C-terminal region of Reelin is not necessary for secretion but is required for efficient activation of downstream signaling. J Biol Chem, 282:20544-52.
10. Förster E, Bock HH, Herz J, Chai X, Frotscher M, Zhao S (2010). Emerging topics in Reelin function. Eur J Neurosci,1-8.
11. Knuesel I (2010). Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases. Prog Neurobiol, 91(4):257-74.
12. Alcantara S, Ruiz M, D'Arcangelo G, Ezan F, de Lecea L, Curran T, Sotelo C, Soriano E (1998). Regional and cellular patterns of reelin mRNA expression in the forebrain of the developing and adult mouse. J Neurosci, 18:7779-99.
13. Cooper JA (2008). A mechanism for inside-out lamination in the neocortex. Trends Neurosci,31:113-9.
14. D'Arcangelo G, Miao GG, Chen SC, Soares HD, Morgan JI, Curran T (1995). A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature, 374:719-23.
15. Hirotsune S, Takahara T, Sasaki N, Hirose K, Yoshiki A, Ohashi T, Kusakabe M, Murakami Y, Muramatsu M, Watanabe S, et al (1995). The reeler gene encodes a protein with an EGF-like motif expressed by pioneer neurons. Nat Genet, 10:77-83.
16. Hiesberger T, TrommsdorffM, Howell BW, Goffinet A, Mumby MC, Cooper JA, Herz J (1999). Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron,24:481-9.
17. Howell BW, Lanier LM, Frank R, Gertler FB, Cooper JA (1999). The disabled 1 phosphotyrosine-binding domain binds to the internalization signals of transmembrane glycoproteins and to phospholipids. Mol Cell Biol,19:5179-88.
18. TrommsdorffM, Gotthardt M, Hiesberger T, Shelton J, Stockinger W, Nimpf J, Hammer RE, Richardson JA, Herz J (1999). Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell, 97:689-701.
19. Hoe HS, Tran TS, Matsuoka Y, Howell BW, Rebeck GW (2006). DAB1 and Reelin effects on amyloid precursor protein and ApoE receptor 2 trafficking and processing. J Biol Chem, 281:35176-85.
20. Homayouni R, Rice DS, Sheldon M, Curran T (1999). Disabled-1 binds to the cytoplasmic domain of amyloid precursor-like protein 1. J Neurosci, 19:7507-15.
21. Strasser V, Fasching D, Hauser C, Mayer H, Bock HH, Hiesberger T, Herz J, Weeber EJ, Sweatt JD, Pramatarova A, Howell B, Schneider WJ, Nimpf J (2004). Receptor clustering is involved in Reelin signaling. Mol Cell Biol, 24:1378-86.
22. TrommsdorffM, Borg JP, Margolis B, Herz J (1998). Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J Biol Chem, 273:33556-60.
23. Bock HH, Jossin Y, Liu P, Forster E, May P, Goffinet AM, Herz J (2003). Phosphatidylinositol 3-kinase interacts with the adaptor protein Dab1 in response to Reelin signaling and is required for normal cortical lamination. J Biol Chem, 278:38772-9.
24. Beffert U, Morfini G, Bock HH, Reyna H, Brady ST, Herz J (2002). Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta. J Biol Chem, 277:49958-64.
25. Beffert U, Weeber EJ, Morfini G, Ko J, Brady ST, Tsai LH, Sweatt JD, Herz J (2004). Reelin and cyclin-dependent kinase 5-dependent signals cooperate in regulating neuronal migration and synaptic transmission. J Neurosci, 24:1897-906.
26. Chai X, Forster E, Zhao S, Bock HH, Frotscher M (2009). Reelin stabilizes the actin cytoskeleton of neuronal processes by inducing n-cofilin phosphorylation at serine3. J Neurosci,29:288-99.
27. Goffinet AM (1984). Events governing organization of postmigratory neurons: studies on brain development in normal and reeler mice. Brain Res,319:261-96.
28. Weeber EJ, Beffert U, Jones C, Christian JM, Forster E, Sweatt JD, Herz J (2002). Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J Biol Chem, 277:39944-52.
29. Hack I, Hellwig S, Junghans D, Brunne B, Bock HH, Zhao S, Frotscher M (2007). Divergent roles of ApoER2 and Vldlr in the migration of cortical neurons. Development, 134:3883-91.
30. Duit S, Mayer H, Blake SM, Schneider WJ, Nimpf J (2010). Differential functions of ApoER2 and very low density lipoprotein receptor in Reelin signaling depend on differential sorting of the receptors. J Biol Chem, 285:4896-908.
31. Arnaud L, Ballif BA (2003), Cooper JA. Regulation of protein tyrosine kinase signaling by substrate degradation during brain development. Mol Cell Biol, 23:9293-302.
32. Bock HH, Jossin Y, May P, Bergner O, Herz J (2004). Apolipoprotein E receptors are required for reelin-induced proteasomal degradation of the neuronal adaptor protein Disabled-1. J Biol Chem, 279:33471-9.
33. Morimura T, Hattori M, Ogawa M, Mikoshiba K (2005). Disabled1 regulates the intracellular trafficking of reelin receptors. J Biol Chem, 280:16901-8.
34. Frotscher M (1998). Cajal-Retzius cells, Reelin, and the formation of layers. Curr Opin Neurobiol, 8:570-5.
35. Abraham H, Meyer G (2003). Reelin-expressing neurons in the postnatal and adult human hippocampal formation. Hippocampus, 13:715-27.
36. Abraham H, Perez-Garcia CG, Meyer G (2004). p73 and Reelin in Cajal-Retzius cells of the developing human hippocampal formation. Cereb Cortex, 14:484-95.
37. Baloyannis SJ (2005). Morphological and morphometric alterations of Cajal-Retzius cells in early cases of Alzheimer's disease: a Golgi and electron microscope study. Int J Neurosci, 15:965-80.
38. Chin J, Massaro CM, Palop JJ, Thwin MT, Yu GQ, Bien-Ly N, Bender A, Mucke L (2007). Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease. J Neurosci, 27:2727-33.
39. Knuesel I, Nyffeler M, Mormede C, Muhia M, Meyer U, Pietropaolo S, Yee BK, Pryce CR, LaFerla FM, Marighetto A, Feldon J (2009). Age-related accumulation of Reelin in amyloid-like deposits. Neurobiol Aging, 30:697-716.
40. Lacor PN, Grayson DR, Auta J, Sugaya I, Costa E, Guidotti A (2000). Reelin secretion from glutamatergic neurons in culture is independent from neurotransmitter regulation. Proc Natl Acad Sci U S A, 97:3556-61.
41. Miettinen R, Riedel A, Kalesnykas G, Kettunen HP, Puolivali J, Soininen H, Arendt T (2005). Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: effects of APP/PS1 genotype and ovariectomy. J Chem Neuroanat, 30:105-18.
42. Pappas GD, Kriho V, Liu WS, Tremolizzo L, Lugli G, Larson J (2003). Immunocytochemical localization of reelin in the olfactory bulb of the heterozygous reeler mouse: an animal model for schizophrenia. Neurol Res, 25:819-30.
43. Pesold C, Impagnatiello F, Pisu MG, Uzunov DP, Costa E, Guidotti A, Caruncho HJ (1998). Reelin is preferentially expressed in neurons synthesizing gamma-aminobutyric acid in cortex and hippocampus of adult rats. Proc Natl Acad Sci U S A, 95:3221-6.
44. Ramos-Moreno T, Galazo MJ, Porrero C, Martinez-Cerdeno V, Clasca F (2006). Extracellular matrix molecules and synaptic plasticity: immunomapping of intracellular and secreted Reelin in the adult rat brain. Eur J Neurosci, 23:401-22.
45. Beffert U, Weeber EJ, Durudas A, Qiu S, Masiulis I, Sweatt JD, Li WP, Adelmann G, Frotscher M, Hammer RE, Herz J (2005). Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2. Neuron, 47:567-79.
46. Forster E, Tielsch A, Saum B, Weiss KH, Johanssen C, Graus-Porta D, Muller U, Frotscher M (2002). Reelin, Disabled 1, and beta 1 integrins are required for the formation of the radial glial scaffold in the hippocampus. Proc Natl Acad Sci U S A, 99:13178-83.
47. Frotscher M, Haas CA, Forster E (2003). Reelin controls granule cell migration in the dentate gyrus by acting on the radial glial scaffold. Cereb Cortex,13:634-40.
48. Bliss TV, Lomo T (1973). Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol, 232:331-56.
49. Chen Y, Beffert U, Ertunc M, Tang TS, Kavalali ET, Bezprozvanny I, Herz J (2005). Reelin modulates NMDA receptor activity in cortical neurons. J Neurosci, 25:8209-16.
50. Herz J, Chen Y (2006). Reelin, lipoprotein receptors and synaptic plasticity. Nat Rev Neurosci,7:850-9.
51. Qiu S, Korwek KM, Pratt-Davis AR, Peters M, Bergman MY, Weeber EJ (2006). Cognitive disruption and altered hippocampus synaptic function in Reelin haploinsufficient mice. Neurobiol Learn Mem,85:228-42.
52. Qiu S, Zhao LF, Korwek KM, Weeber EJ (2006). Differential reelin-induced enhancement of NMDA and AMPA receptor activity in the adult hippocampus. J Neurosci, 26:12943-55.
53. Malenka RC (2003). The long-term potential of LTP. Nat Rev Neurosci,4:923-6.
54. Gotthardt M, TrommsdorffM, Nevitt MF, Shelton J, Richardson JA, Stockinger W, Nimpf J, Herz J (2000). Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction. J Biol Chem, 275:25616-24.
55. Stockinger W, Brandes C, Fasching D, Hermann M, Gotthardt M, Herz J, Schneider WJ, Nimpf J (2000). The reelin receptor ApoER2 recruits JNK-interacting proteins-1 and -2. J Biol Chem, 275:25625-32.
56. Jossin Y, Goffinet AM (2007). Reelin signals through phosphatidylinositol 3-kinase and Akt to control cortical development and through mTor to regulate dendritic growth. Mol Cell Biol,27:7113-24.
57. Matsuki T, Pramatarova A, Howell BW (2008). Reduction of Crk and CrkL expression blocks reelin-induced dendritogenesis. J Cell Sci, 121:1869-75.
58. Niu S, Renfro A, Quattrocchi CC, Sheldon M, D'Arcangelo G (2004). Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway. Neuron, 41:71-84.
59. Niu S, Yabut O, D'Arcangelo G (2008). The Reelin signaling pathway promotes dendritic spine development in hippocampal neurons. J Neurosci, 28:10339-48.
60. Stanfield BB, Cowan WM (1979). The morphology of the hippocampus and dentate gyrus in normal and reeler mice. J Comp Neurol, 185:393-422.
61. Stanfield BB, Cowan WM (1979). The development of the hippocampus and dentate gyrus in normal and reeler mice. J Comp Neurol, 185:423-59.
62. Liu WS, Pesold C, Rodriguez MA, Carboni G, Auta J, Lacor P, Larson J, Condie BG, Guidotti A, Costa E (2001). Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse. Proc Natl Acad Sci U S A, 98:3477-82.
63. Pappas GD, Kriho V, Pesold C (2001). Reelin in the extracellular matrix and dendritic spines of the cortex and hippocampus: a comparison between wild type and heterozygous reeler mice by immunoelectron microscopy. J Neurocytol, 30:413-25.
64. Tueting P, Costa E, Dwivedi Y, Guidotti A, Impagnatiello F, Manev R, Pesold C (1999). The phenotypic characteristics of heterozygous reeler mouse. Neuroreport, 10:1329-34.
65. Pujadas L, Gruart A, Bosch C, Delgado L, Teixeira CM, Rossi D, de Lecea L, Martinez A, Delgado-Garcia JM, Soriano E (2010). Reelin regulates postnatal neurogenesis and enhances spine hypertrophy and long-term potentiation. J Neurosci, 30:4636-49.
66. Meyer G, Goffinet AM (1998). Prenatal development of reelin-immunoreactive neurons in the human neocortex. J Comp Neurol, 397:29-40.
67. Ogawa M, Miyata T, Nakajima K, Yagyu K, Seike M, Ikenaka K, Yamamoto H, Mikoshiba K (1995). The reeler gene-associated antigen on Cajal-Retzius neurons is a crucial molecule for laminar organization of cortical neurons. Neuron, 14:899-912.
68. Hong SE, Shugart YY, Huang DT, Shahwan SA, Grant PE, Hourihane JO, Martin ND, Walsh CA (2000). Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat Genet, 26:93-6.
69. Belichenko PV, Vogt Weisenhorn DM, Myklossy J, Celio MR (1995). Calretinin-positive Cajal-Retzius cells persist in the adult human neocortex. Neuroreport, 6:1869-74.
70. Martin R, Gutierrez A, Penafiel A, Marin-Padilla M, de la Calle A (1999). Persistence of Cajal-Retzius cells in the adult human cerebral cortex. An immunohistochemical study. Histol Histopathol, 14:487-90.
71. Mikkonen M, Soininen H, Pitkanen A (1997). Distribution of parvalbumin-, calretinin-, and calbindin-D28k-immunoreactive neurons and fibers in the human entorhinal cortex. J Comp Neurol, 388:64-88.
72. Riedel A, Miettinen R, Stieler J, Mikkonen M, AlafuzoffI, Soininen H, Arendt T (2003). Reelin-immunoreactive Cajal-Retzius cells: the entorhinal cortex in normal aging and Alzheimer's disease. Acta Neuropathol, 106:291-302.
73. Roberts RC, Xu L, Roche JK, Kirkpatrick B (2005). Ultrastructural localization of reelin in the cortex in post-mortem human brain. J Comp Neurol, 482:294-308.
74. Martinez-Cerdeno V, Galazo MJ, Clasca F (2003). Reelin-immunoreactive neurons, axons, and neuropil in the adult ferret brain: evidence for axonal secretion of reelin in long axonal pathways. J Comp Neurol, 463:92-116.
75. Martinez-Cerdeno V, Galazo MJ, Cavada C, Clasca F (2002). Reelin immunoreactivity in the adult primate brain: intracellular localization in projecting and local circuit neurons of the cerebral cortex, hippocampus and subcortical regions. Cereb Cortex, 12:1298-311.
76. Deguchi K, Inoue K, Avila WE, Lopez-Terrada D, Antalffy BA, Quattrocchi CC, Sheldon M, Mikoshiba K, D'Arcangelo G, Armstrong DL (2003). Reelin and disabled-1 expression in developing and mature human cortical neurons. J Neuropathol Exp Neurol, 62:676-84.
77. Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR, Impagnatiello F, Pandey G, Pesold C, Sharma R, Uzunov D, Costa E (2000). Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry, 57:1061-9.
78. Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG, Uzunov DP, Smalheiser NR, Davis JM, Pandey GN, Pappas GD, Tueting P, Sharma RP, Costa E (1998). A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci U S A, 95:15718-23.
79. Kramer PL, Xu H, Woltjer RL, Westaway SK, Clark D, Erten-Lyons D, Kaye JA, Welsh-Bohmer KA, Troncoso JC, Markesbery WR, Petersen RC, Turner RS, Kukull WA, Bennett DA, Galasko D, Morris JC, Ott J (2010). Alzheimer disease pathology in cognitively healthy elderly: A genome-wide study. Neurobiol Aging, in press.
80. Seripa D, Matera MG, Franceschi M, Daniele A, Bizzarro A, Rinaldi M, Panza F, Fazio VM, Gravina C, D'Onofrio G, Solfrizzi V, Masullo C, Pilotto A (2008). The RELN locus in Alzheimer's disease. J Alzheimers Dis, 14:335-44.
81. Savla GN, Palmer BW (2005). Neuropsychology in Alzheimer's disease and other dementia research. Curr Opin Psychiatry, 18:621-7.
82. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986). Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A,83:4913-7.
83. Glenner GG, Wong CW (1984). Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun, 120:885-90.
84. Estus S, Golde TE, Kunishita T, Blades D, Lowery D, Eisen M, Usiak M, Qu XM, Tabira T, Greenberg BD, et al (1992). Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science, 255:726-8.
85. Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ (1992). Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature, 357:500-3.
86. Furukawa K, Sopher BL, Rydel RE, Begley JG, Pham DG, Martin GM, Fox M, Mattson MP (1996). Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J Neurochem, 67:1882-96.
87. Gao Y, Pimplikar SW (2001). The gamma -secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus. Proc Natl Acad Sci U S A, 98:14979-84.
88. von Rotz RC, Kohli BM, Bosset J, Meier M, Suzuki T, Nitsch RM, Konietzko U (2004). The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J Cell Sci, 117:4435-48.
89. Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M (2009). APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature, 457:981-9.
90. Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, Lambert MP, Velasco PT, Bigio EH, Finch CE, Krafft GA, Klein WL (2004). Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci, 24:10191-200.
91. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998). Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A, 95:6448-53.
92. Selkoe DJ (2002). Alzheimer's disease is a synaptic failure. Science, 298:789-91.
93. Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, Malinow R (2006). AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron, 52:831-43.
94. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, Sisodia S, Malinow R (2003). APP processing and synaptic function. Neuron, 37:925-37.
95. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Greengard P (2005). Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci, 8:1051-8.
96. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL (2007). Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci, 27:2866-75.
97. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008). Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med, 14:837-42.
98. Townsend M, Shankar GM, Mehta T, Walsh DM, Selkoe DJ (2006). Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J Physiol, 572:477-92.
99. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002). Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature, 416:535-9.
100. Durakoglugil MS, Chen Y, White CL, Kavalali ET, Herz J (2009). Reelin signaling antagonizes beta-amyloid at the synapse. Proc Natl Acad Sci U S A, 106:15938-43.
101. Botella-Lopez A, Burgaya F, Gavin R, Garcia-Ayllon MS, Gomez-Tortosa E, Pena-Casanova J, Urena JM, Del Rio JA, Blesa R, Soriano E, Saez-Valero J (2006). Reelin expression and glycosylation patterns are altered in Alzheimer's disease. Proc Natl Acad Sci U S A, 103:5573-8.
102. Botella-Lopez A, Cuchillo-Ibanez I, Cotrufo T, Mok SS, Li QX, Barquero MS, Dierssen M, Soriano E, Saez-Valero J (2010). Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease. Neurobiol Dis, 37:682-91.
103. Saez-Valero J, Costell M, Sjogren M, Andreasen N, Blennow K, Luque JM (2003). Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease. J Neurosci Res, 72:132-6.
104. Hibi T, Hattori M (2009). The N-terminal fragment of Reelin is generated after endocytosis and released through the pathway regulated by Rab11. FEBS Lett, 583:1299-303.
105. Doehner J, Madhusudan A, Konietzko U, Fritschy JM, Knuesel I (2010). Co-localization of Reelin and proteolytic AbetaPP fragments in hippocampal plaques in aged wild-type mice. J Alzheimers Dis, 19:1339-57.
106. Motoi Y, Itaya M, Mori H, Mizuno Y, Iwasaki T, Hattori H, Haga S, Ikeda K (2004). Apolipoprotein E receptor 2 is involved in neuritic plaque formation in APP sw mice. Neurosci Lett, 368:144-7.
107. Wirths O, Multhaup G, Czech C, Blanchard V, Tremp G, Pradier L, Beyreuther K, Bayer TA (2001). Reelin in plaques of beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci Lett, 316:145-8.
108. Madhusudan A, Sidler C, Knuesel I (2009). Accumulation of reelin-positive plaques is accompanied by a decline in basal forebrain projection neurons during normal aging. Eur J Neurosci, 30:1064-76.
109. Gold PE (2003). Acetylcholine modulation of neural systems involved in learning and memory. Neurobiol Learn Mem, 80:194-210.
110. Knobloch M, Konietzko U, Krebs DC, Nitsch RM (2007). Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice. Neurobiol Aging, 28:1297-306.
111. Kocherhans S, Madhusudan A, Doehner J, Breu KS, Nitsch RM, Fritschy JM, Knuesel I (2010). Reduced Reelin expression accelerates amyloid-β plaque formation and Tau pathology in transgenic AD mice. J Neurosci, ;in press.
112. Fung J, Frost D, Chakrabartty A, McLaurin J (2004). Interaction of human and mouse Abeta peptides. J Neurochem, 91:1398-403.
113. Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K (1991). Human and rodent sequence analogs of Alzheimer's amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4. Eur J Biochem, 201:61-9.
114. Lucin KM, Wyss-Coray T (2009). Immune activation in brain aging and neurodegeneration: too much or too little? Neuron, 64:110-22.
115. Parachikova A, Agadjanyan MG, Cribbs DH, Blurton-Jones M, Perreau V, Rogers J, Beach TG, Cotman CW (2007). Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol Aging, 28:1821-33.
116. Hoozemans JJ, Veerhuis R, Rozemuller JM, Eikelenboom P (2006). Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology. Int J Dev Neurosci, 24:157-65.
117. Salminen A, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T (2009). Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol, 87:181-94.
118. McGeer PL, McGeer EG (2002). Local neuroinflammation and the progression of Alzheimer's disease. J Neurovirol, 8:529-38.
119. Wyss-Coray T (2006). Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med, 12:1005-1015.
120. Grathwohl SA, Kalin RE, Bolmont T, Prokop S, Winkelmann G, Kaeser SA, Odenthal J, Radde R, Eldh T, Gandy S, Aguzzi A, Staufenbiel M, Mathews PM, Wolburg H, Heppner FL, Jucker M (2009). Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia. Nat Neurosci, 12:1361-3.
121. Deverman BE, Patterson PH (2009). Cytokines and CNS development. Neuron, 64:61-78.
122. Patterson PH (2009). Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res, 204:313-21.
123. Penner JD, Brown AS (2007). Prenatal infectious and nutritional factors and risk of adult schizophrenia. Expert Rev Neurother, 7:797-805.
124. Meyer U, Feldon J, Schedlowski M, Yee BK (2005). Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev, 29:913-47.
125. Shi L, Fatemi SH, Sidwell RW, Patterson PH (2003). Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci, 23:297-302.
126. Zuckerman L, Rehavi M, Nachman R, Weiner I (2003). Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology, 28:1778-89.
127. Meyer U, Nyffeler M, Engler A, Urwyler A, Schedlowski M, Knuesel I, Yee BK, Feldon J (2006). The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci, 26:4752-62.
128. Meyer U, Nyffeler M, Schwendener S, Knuesel I, Yee BK, Feldon J (2008). Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology, 33:441-56.
129. Meyer U, Nyffeler M, Yee BK, Knuesel I, Feldon J (2008). Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun, 22:469-86.
130. Nyffeler M, Meyer U, Yee BK, Feldon J, Knuesel I (2006). Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: implications for schizophrenia. Neuroscience, 143:51-62.
131. Park TJ, Curran T (2008). Crk and Crk-like play essential overlapping roles downstream of disabled-1 in the Reelin pathway. J Neurosci, 28:13551-62.
132. Suetsugu S, Tezuka T, Morimura T, Hattori M (2004), Mikoshiba K, Yamamoto T, Takenawa T. Regulation of actin cytoskeleton by mDab1 through N-WASP and ubiquitination of mDab1. Biochem J, 384:1-8.
133. Qiu S, Weeber EJ (2007). Reelin signaling facilitates maturation of CA1 glutamatergic synapses. J Neurophysiol, 97:2312-21.
134. Borrell V, Del Rio JA, Alcantara S, Derer M, Martinez A, D'Arcangelo G, Nakajima K, Mikoshiba K, Derer P, Curran T, Soriano E (1999). Reelin regulates the development and synaptogenesis of the layer-specific entorhino-hippocampal connections. J Neurosci, 19:1345-58.
135. Borrell V, Pujadas L, Simo S, Dura D, Sole M, Cooper JA, Del Rio JA, Soriano E (2007). Reelin and mDab1 regulate the development of hippocampal connections. Mol Cell Neurosci, 36:158-73.
136. Del Rio JA, Heimrich B, Borrell V, Forster E, Drakew A, Alcantara S, Nakajima K, Miyata T, Ogawa M, Mikoshiba K, Derer P, Frotscher M, Soriano E (1997). A role for Cajal-Retzius cells and reelin in the development of hippocampal connections. Nature, 385:70-4.
137. Ohkubo N, Lee YD, Morishima A, Terashima T, Kikkawa S, Tohyama M, Sakanaka M, Tanaka J, Maeda N, Vitek MP, Mitsuda N (2003). Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3beta cascade. Faseb, 17:295-7.